Results Wire: US FDA Advisory Committee Votes Unanimously to Recommend Approval of Luxturna, a Gene Therapy Proposed by Spark Therapeutics to Treat a Rare, Genetic Vision Disease Report
Results Wire: US FDA Advisory Committee Votes Unanimously to Recommend Approval of Luxturna, a Gene Therapy Proposed by Spark Therapeutics to Treat a Rare, Genetic Vision Disease Report